Truist Financial Maintains Option Care Health(OPCH.US) With Buy Rating, Maintains Target Price $34
Option Care Health Analyst Ratings
Goldman Sachs Downgrades Option Care Health(OPCH.US) to Hold Rating, Cuts Target Price to $27
A Quick Look at Today's Ratings for Option Care Health(OPCH.US), With a Forecast Between $26 to $34
Option Care Health Is Maintained at Outperform by Barrington Research
Option Care Health Price Target Cut to $32.00/Share From $40.00 by Barrington Research
Truist Financial Maintains Option Care Health(OPCH.US) With Buy Rating, Announces Target Price $34
Option Care Health Cut to Hold From Buy by Jefferies
Option Care Health Analyst Ratings
BofA Securities Downgrades Option Care Health to Neutral From Buy, Price Target Is $29
Jefferies Downgrades Option Care Health(OPCH.US) to Hold Rating, Cuts Target Price to $26
JMP Securities Maintains Option Care Health(OPCH.US) With Buy Rating, Cuts Target Price to $31
Barrington Maintains Option Care Health(OPCH.US) With Buy Rating, Maintains Target Price $40
Option Care Health's Strategic Growth and Improved Profitability Justifies Buy Rating With $40 Target
JMP Securities Maintains Option Care Health(OPCH.US) With Buy Rating, Maintains Target Price $37
Option Care Health Is Maintained at Market Outperform by JMP Securities
Option Care Health Analyst Ratings
JMP Securities Maintains Option Care Health(OPCH.US) With Buy Rating, Raises Target Price to $37
Buy Rating Affirmed for Option Care Health on Strong Growth Prospects and Solid Financials
Deutsche Bank Maintains Option Care Health(OPCH.US) With Buy Rating, Maintains Target Price $36